Trulieve Cannabis (TRLV) Research & Development (2020 - 2024)

Trulieve Cannabis has reported Research & Development for 5 years, with the latest figure at $66.7 million in Q4 2024.

• On a quarterly basis, Research & Development rose 13.13% year-over-year to $66.7 million in Q4 2024; TTM through Dec 2024 was $257.7 million, a 7.31% increase from a year earlier, with the FY2024 full-year figure at $257.7 million, up 7.31% from the prior year.
• Research & Development was $66.7 million for Q4 2024 at Trulieve Cannabis, roughly flat from $66.7 million in the prior quarter.
• The five-year high for Research & Development was $74.3 million in Q3 2022, with the low at $22.9 million in Q1 2020.
• Average Research & Development over 5 years is $55.4 million, with a median of $60.1 million recorded in 2023.
• The sharpest annual moves came in 2021 and 2023: Research & Development soared 94.87% in 2021, then fell 20.09% in 2023.
• Over 5 years, Research & Development stood at $38.6 million in 2020, then soared by 78.73% to $69.0 million in 2021, then dropped by 16.17% to $57.9 million in 2022, then rose by 1.86% to $59.0 million in 2023, then advanced by 13.13% to $66.7 million in 2024.
• The last three Research & Development figures came in at $66.7 million (Q4 2024), $66.7 million (Q3 2024), and $63.2 million (Q2 2024), per Business Quant data.